Unihealth Hospitals Ltd
Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]
- Market Cap ₹ 243 Cr.
- Current Price ₹ 158
- High / Low ₹ 178 / 109
- Stock P/E 66.2
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 8.91 %
- ROE 7.88 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Earnings include an other income of Rs.2.87 Cr.
- Company has high debtors of 225 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|
| 0.63 | 1.61 | 1.92 | 4.23 | 4.87 | |
| 0.74 | 0.79 | 1.36 | 2.28 | 2.42 | |
| Operating Profit | -0.11 | 0.82 | 0.56 | 1.95 | 2.45 |
| OPM % | -17.46% | 50.93% | 29.17% | 46.10% | 50.31% |
| -0.14 | 0.94 | 1.79 | 2.33 | 2.87 | |
| Interest | 0.80 | 1.19 | 1.15 | 0.34 | 0.02 |
| Depreciation | 0.11 | 0.09 | 0.08 | 0.16 | 0.25 |
| Profit before tax | -1.16 | 0.48 | 1.12 | 3.78 | 5.05 |
| Tax % | 0.00% | 0.00% | -19.64% | 19.84% | |
| -1.16 | 0.48 | 1.34 | 3.04 | 3.67 | |
| EPS in Rs | |||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 89% |
| TTM: | 120% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 67% |
| TTM: | 127% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 13% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|
| Equity Capital | 1.34 | 1.39 | 15.40 | 15.40 |
| Reserves | 5.17 | 11.28 | 49.07 | 50.20 |
| 11.60 | 12.08 | 3.30 | 1.15 | |
| 0.42 | 0.61 | 0.71 | 1.05 | |
| Total Liabilities | 18.53 | 25.36 | 68.48 | 67.80 |
| 1.50 | 1.42 | 3.09 | 3.21 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 6.15 | 6.34 | 18.37 | 23.05 |
| 10.88 | 17.60 | 47.02 | 41.54 | |
| Total Assets | 18.53 | 25.36 | 68.48 | 67.80 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| 2.25 | 1.97 | -2.46 | ||
| -6.13 | -7.17 | -10.50 | ||
| 3.93 | 5.09 | 39.57 | ||
| Net Cash Flow | 0.05 | -0.11 | 26.61 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Debtor Days | 476.09 | 117.86 | 225.21 | |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 476.09 | 117.86 | 225.21 | |
| Working Capital Days | 630.25 | 212.92 | 361.55 | |
| ROCE % | 10.59% | 8.91% |
Documents
Announcements
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
21 April 2025 - UniHealth exempt from quarterly Corporate Governance report filing for Q4 FY25 as SME listed company.
-
Analysts/Institutional Investor Meet/Con. Call Updates
16 April 2025 - Outcome of analyst/investor group meeting; no UPSI shared.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
16 April 2025 - Certificate under SEBI Regulation 74(5) for dematerialization of securities.
-
Analysts/Institutional Investor Meet/Con. Call Updates
11 April 2025 - Schedule of analyst/institutional investor meeting on April 16, 2025.
-
Shareholders meeting
9 April 2025 - EGM approves preferential issuance of convertible warrants to promoters
Annual reports
Concalls
-
Nov 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Nov 2023Transcript PPT
Business Overview:[1]
a) UHCL is an ISO 9001:2015 certified healthcare service provider with a global presence, especially in Africa.
b) The company operates medical centers and hospitals, provides consultancy services, distributes pharmaceutical and medical consumable products, and offers medical value travel.
c) UHCL is involved in healthcare consultancy projects in India and various African countries, and exports and distributes pharma and medical consumable products to Uganda, Tanzania, and Nigeria.
d) It acts as a distributor for several Indian manufacturers in these African nations.
e) The company has 4 centers and 2 hospitals, with over 150 doctors and specialists treating more than 1.10 lakh patients annually.
f) UHCL manages two multi-specialty facilities with a total of 200 operational beds and has over 1,200 beds in projects under consultancy.